The Impact of Litigation-Associated Reports on Signal Identification in the US FDA's Adverse Event Reporting System

Monica A Muñoz¹, Gerald J Dal Pan²

• ¹Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. monica.munoz@fda.hhs.gov.+1